Announcement
23 Dec 2021
On 23 December 2021, the EIB provided financing worth EUR 15 million (USD 17 million) to support French company Lysogene in the development of its gene therapy products.
Source
Sign in to access
Number of interventions
2
2 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
23 Dec 2021
Revocation date:
No revocation date
Updated: 23 Dec 2021
Loan guarantee
In force
The EIB's EUR 15 million loan (USD 17 million) to Lysogene on 23 December 2021 was backed by a guarantee from the Pan-European Guarantee Fund (EGF, see related state act).
The EGF...
Sign in to see more
Updated: 23 Dec 2021
State loan
In force
On 23 December 2021, the European Investment Bank (EIB) and Lysogene Sa signed a loan agreement worth EUR 15 million (approx. USD 17 million) to support French company Lysogene in the development o...
Sign in to see more
Related State Acts
Threads
See all
This state act is not part of any Thread yet.